• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 0.00% 46.0¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives grant from US Department of Defence

Announcements


RCE Investor Presentation21/11/18 download Created with Sketch. 4.59MB
RCE Appendix 4C and commentaryPRICE SENSITIVE01/11/18 download Created with Sketch. 336.62KB
RCE Notice of General Meeting/Proxy Form29/10/18 download Created with Sketch. 1.29MB
RCE Recce Meets Antibiotic Leaders to Explore Opportunities25/10/18 download Created with Sketch. 1.95MB
RCE Date of 2018 Annual General Meeting08/10/18 download Created with Sketch. 118.09KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE02/10/18 download Created with Sketch. 355.26KB
RCE Appendix 4G28/09/18 download Created with Sketch. 100.09KB
RCE 2018 Annual Report28/09/18 download Created with Sketch. 7.41MB
RCE Change of Registry Address: Automic P/L - Sydney Office28/09/18 download Created with Sketch. 91.41KB
RCE Funding UpdatePRICE SENSITIVE13/09/18 download Created with Sketch. 191.19KB
RCE Investor Presentation12/09/18 download Created with Sketch. 1.22MB
RCE Investor Presentation04/09/18 download Created with Sketch. 1.14MB
RCE Appendix 4E - Preliminary Final ReportPRICE SENSITIVE31/08/18 download Created with Sketch. 254.44KB
RCE Key Australian Patent for Recce's Broad-Spectrum AntibioticsPRICE SENSITIVE31/07/18 download Created with Sketch. 427.82KB
RCE Appendix 4C and commentaryPRICE SENSITIVE30/07/18 download Created with Sketch. 968.99KB
RCE Update on Progress of Broad Spectrum Antibiotic RECCE 327PRICE SENSITIVE17/07/18 download Created with Sketch. 180.48KB
RCE Change of Share Registry16/07/18 download Created with Sketch. 118.78KB
RCE Recce Presented at FNN/Shaw and Partners Investor Conference21/06/18 download Created with Sketch. 321.34KB
RCE Update on meeting with US FDAPRICE SENSITIVE05/06/18 download Created with Sketch. 520.35KB
RCE Investor Presentation05/06/18 download Created with Sketch. 2.3MB
RCE Recce Pharmaceuticals to Present at Investor Conference30/05/18 download Created with Sketch. 135.61KB
RCE Update on meeting with US FDA16/05/18 download Created with Sketch. 182.04KB
RCE Cleansing Statement01/05/18 download Created with Sketch. 128.62KB
RCE Appendix 3B01/05/18 download Created with Sketch. 156.51KB
RCE Appendix 4C and commentaryPRICE SENSITIVE30/04/18 download Created with Sketch. 209.11KB
RCE Initial Director's Interest Notice27/04/18 download Created with Sketch. 29.71KB
RCE Pharmaceutical Expert Joins Board of Directors24/04/18 download Created with Sketch. 189.65KB
RCE Additional AU$861,590 R&D Tax Incentive Rebate ReceivedPRICE SENSITIVE23/04/18 download Created with Sketch. 194.32KB
RCE RECCE Antibiotic International Media Attention19/04/18 download Created with Sketch. 191.83KB
RCE April Funding Update28/03/18 download Created with Sketch. 188.81KB
RCE Meeting with US FDA on Phase I Clinical Trial for RECCE 32708/03/18 download Created with Sketch. 188.63KB
RCE Recce Half Yearly Report and Appendix 4DPRICE SENSITIVE28/02/18 download Created with Sketch. 222.52KB
RCE Cleansing Statement16/02/18 download Created with Sketch. 128.63KB
RCE Appendix 3B16/02/18 download Created with Sketch. 158.72KB
RCE Results of Meeting16/02/18 download Created with Sketch. 283.82KB
RCE Data Submission & Further Communication Request with US FDAPRICE SENSITIVE15/02/18 download Created with Sketch. 187.98KB
RCE Investor Presentation31/01/18 download Created with Sketch. 2.6MB
RCE Appendix 4C and commentaryPRICE SENSITIVE31/01/18 download Created with Sketch. 203.09KB
RCE Recce to present at two investor conferences25/01/18 download Created with Sketch. 148.66KB
RCE Notice of General Meeting/Proxy Form17/01/18 download Created with Sketch. 548.34KB
RCE Cleansing Statement17/01/18 download Created with Sketch. 128.65KB
RCE Appendix 3B17/01/18 download Created with Sketch. 158.57KB
RCE Appendix 3B15/01/18 download Created with Sketch. 152.08KB
RCE AusIndustry Awards Recce Financial SupportPRICE SENSITIVE15/01/18 download Created with Sketch. 300.59KB
RCE Shares to be released from Escrow10/01/18 download Created with Sketch. 125.82KB
RCE Broker Presentation11/12/17 download Created with Sketch. 1.87MB
RCE Cleansing Statement04/12/17 download Created with Sketch. 128.56KB
RCE Appendix 3B04/12/17 download Created with Sketch. 158.72KB
RCE Company Secretary Appointment/Resignation29/11/17 download Created with Sketch. 207.83KB
RCE Results of Meeting21/11/17 download Created with Sketch. 277.26KB
RCE 2017 AGM Presentation21/11/17 download Created with Sketch. 819.39KB
RCE US FDA Grants Qualified Infectious Disease Product DesignatiPRICE SENSITIVE16/11/17 download Created with Sketch. 279.16KB
RCE Trading Halt Request14/11/17 download Created with Sketch. 211.05KB
RCE Trading HaltPRICE SENSITIVE14/11/17 download Created with Sketch. 251.91KB
RCE Change in Sydney Office Address08/11/17 download Created with Sketch. 203.7KB
RCE Cleansing Statement03/11/17 download Created with Sketch. 78.81KB
RCE Appendix 3B03/11/17 download Created with Sketch. 568.49KB
RCE Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 211.6KB
RCE Change in substantial holding25/10/17 download Created with Sketch. 1.64MB
RCE Appendix 3B25/10/17 download Created with Sketch. 566.36KB
RCE Successful Share Purchase Plan23/10/17 download Created with Sketch. 244.96KB
RCE Notice of Annual General Meeting/Proxy Form20/10/17 download Created with Sketch. 608.16KB
RCE Appendix 4G20/10/17 download Created with Sketch. 255.61KB
RCE Annual Report to shareholders20/10/17 download Created with Sketch. 4.39MB
RCE Cleansing Statement03/10/17 download Created with Sketch. 78.82KB
RCE Appendix 3B03/10/17 download Created with Sketch. 569.1KB
RCE Recce Launches Share Purchase PlanPRICE SENSITIVE27/09/17 download Created with Sketch. 464.2KB
RCE Correction to Appendix 3B26/09/17 download Created with Sketch. 449.06KB
RCE Cleansing Statement25/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B25/09/17 download Created with Sketch. 297.11KB
RCE Response to ASX Price QueryPRICE SENSITIVE18/09/17 download Created with Sketch. 612.45KB
RCE Investor Presention15/09/17 download Created with Sketch. 1.64MB
RCE Cleansing Statement07/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B07/09/17 download Created with Sketch. 335.73KB
RCE Recce Confirms Pre-IND Data Submission to US FDAPRICE SENSITIVE07/09/17 download Created with Sketch. 244.64KB
RCE Appendix 4E and Financial ReportPRICE SENSITIVE01/09/17 download Created with Sketch. 1.46MB
RCE Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 212.83KB
RCE Recce Confirms Delivery by Intravenous DripPRICE SENSITIVE31/07/17 download Created with Sketch. 800.89KB
RCE Cleansing Statement20/07/17 download Created with Sketch. 78.81KB
RCE Appendix 3B20/07/17 download Created with Sketch. 335.13KB
RCE Recce achieves milestone with volume productionPRICE SENSITIVE20/07/17 download Created with Sketch. 336.66KB
RCE Cleansing Statement22/06/17 download Created with Sketch. 78.75KB
RCE Appendix 3B22/06/17 download Created with Sketch. 426.06KB
RCE Recce constructs automated manufacturing facility to supportPRICE SENSITIVE22/06/17 download Created with Sketch. 335.97KB
RCE Recce secures up to A$6.05 million investment agreement withPRICE SENSITIVE16/06/17 download Created with Sketch. 326.06KB
RCE Recce moves closer to clinical study applicationPRICE SENSITIVE19/05/17 download Created with Sketch. 337.1KB
RCE Appendic 4G16/05/17 download Created with Sketch. 253.55KB
RCE Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 210.77KB
RCE Recce calls for Australian investment in R&D to develop new19/04/17 download Created with Sketch. 325.49KB
RCE Operational UpdatePRICE SENSITIVE10/04/17 download Created with Sketch. 1MB
RCE Data from large animal study shows RECCE 327 well toleratedPRICE SENSITIVE27/03/17 download Created with Sketch. 198.96KB
RCE Ceasing to be a substantial holder15/03/17 download Created with Sketch. 155.48KB
RCE Ceasing to be a substantial holder15/03/17 download Created with Sketch. 473.01KB
RCE Change of Director's Interest Notice09/03/17 download Created with Sketch. 247.25KB
RCE Appendix 4D and Interim Financial StatementsPRICE SENSITIVE28/02/17 download Created with Sketch. 731.01KB
RCE Microscopy Images of its Synthetic Antibiotic in Action DestPRICE SENSITIVE24/02/17 download Created with Sketch. 622.67KB
RCE Recce to suspend anti-cancer programPRICE SENSITIVE23/02/17 download Created with Sketch. 185.91KB
RCE Ceasing to be a substantial holder07/02/17 download Created with Sketch. 709.79KB
RCE Operational Update and Quarterly Cash FlowPRICE SENSITIVE30/01/17 download Created with Sketch. 336.12KB
RCE Director Appointment/Resignation23/01/17 download Created with Sketch. 182.16KB
RCE Investor Presentation
21/11/18 download Created with Sketch. 4.59MB
RCE Appendix 4C and commentary
01/11/18PRICE SENSITIVE download Created with Sketch. 336.62KB
RCE Notice of General Meeting/Proxy Form
29/10/18 download Created with Sketch. 1.29MB
RCE Recce Meets Antibiotic Leaders to Explore Opportunities
25/10/18 download Created with Sketch. 1.95MB
RCE Date of 2018 Annual General Meeting
08/10/18 download Created with Sketch. 118.09KB
RCE R&D Incentive Rebate Received
02/10/18PRICE SENSITIVE download Created with Sketch. 355.26KB
RCE Appendix 4G
28/09/18 download Created with Sketch. 100.09KB
RCE 2018 Annual Report
28/09/18 download Created with Sketch. 7.41MB
RCE Change of Registry Address: Automic P/L - Sydney Office
28/09/18 download Created with Sketch. 91.41KB
RCE Funding Update
13/09/18PRICE SENSITIVE download Created with Sketch. 191.19KB
RCE Investor Presentation
12/09/18 download Created with Sketch. 1.22MB
RCE Investor Presentation
04/09/18 download Created with Sketch. 1.14MB
RCE Appendix 4E - Preliminary Final Report
31/08/18PRICE SENSITIVE download Created with Sketch. 254.44KB
RCE Key Australian Patent for Recce's Broad-Spectrum Antibiotics
31/07/18PRICE SENSITIVE download Created with Sketch. 427.82KB
RCE Appendix 4C and commentary
30/07/18PRICE SENSITIVE download Created with Sketch. 968.99KB
RCE Update on Progress of Broad Spectrum Antibiotic RECCE 327
17/07/18PRICE SENSITIVE download Created with Sketch. 180.48KB
RCE Change of Share Registry
16/07/18 download Created with Sketch. 118.78KB
RCE Recce Presented at FNN/Shaw and Partners Investor Conference
21/06/18 download Created with Sketch. 321.34KB
RCE Update on meeting with US FDA
05/06/18PRICE SENSITIVE download Created with Sketch. 520.35KB
RCE Investor Presentation
05/06/18 download Created with Sketch. 2.3MB
RCE Recce Pharmaceuticals to Present at Investor Conference
30/05/18 download Created with Sketch. 135.61KB
RCE Update on meeting with US FDA
16/05/18 download Created with Sketch. 182.04KB
RCE Cleansing Statement
01/05/18 download Created with Sketch. 128.62KB
RCE Appendix 3B
01/05/18 download Created with Sketch. 156.51KB
RCE Appendix 4C and commentary
30/04/18PRICE SENSITIVE download Created with Sketch. 209.11KB
RCE Initial Director's Interest Notice
27/04/18 download Created with Sketch. 29.71KB
RCE Pharmaceutical Expert Joins Board of Directors
24/04/18 download Created with Sketch. 189.65KB
RCE Additional AU$861,590 R&D Tax Incentive Rebate Received
23/04/18PRICE SENSITIVE download Created with Sketch. 194.32KB
RCE RECCE Antibiotic International Media Attention
19/04/18 download Created with Sketch. 191.83KB
RCE April Funding Update
28/03/18 download Created with Sketch. 188.81KB
RCE Meeting with US FDA on Phase I Clinical Trial for RECCE 327
08/03/18 download Created with Sketch. 188.63KB
RCE Recce Half Yearly Report and Appendix 4D
28/02/18PRICE SENSITIVE download Created with Sketch. 222.52KB
RCE Cleansing Statement
16/02/18 download Created with Sketch. 128.63KB
RCE Appendix 3B
16/02/18 download Created with Sketch. 158.72KB
RCE Results of Meeting
16/02/18 download Created with Sketch. 283.82KB
RCE Data Submission & Further Communication Request with US FDA
15/02/18PRICE SENSITIVE download Created with Sketch. 187.98KB
RCE Investor Presentation
31/01/18 download Created with Sketch. 2.6MB
RCE Appendix 4C and commentary
31/01/18PRICE SENSITIVE download Created with Sketch. 203.09KB
RCE Recce to present at two investor conferences
25/01/18 download Created with Sketch. 148.66KB
RCE Notice of General Meeting/Proxy Form
17/01/18 download Created with Sketch. 548.34KB
RCE Cleansing Statement
17/01/18 download Created with Sketch. 128.65KB
RCE Appendix 3B
17/01/18 download Created with Sketch. 158.57KB
RCE Appendix 3B
15/01/18 download Created with Sketch. 152.08KB
RCE AusIndustry Awards Recce Financial Support
15/01/18PRICE SENSITIVE download Created with Sketch. 300.59KB
RCE Shares to be released from Escrow
10/01/18 download Created with Sketch. 125.82KB
RCE Broker Presentation
11/12/17 download Created with Sketch. 1.87MB
RCE Cleansing Statement
04/12/17 download Created with Sketch. 128.56KB
RCE Appendix 3B
04/12/17 download Created with Sketch. 158.72KB
RCE Company Secretary Appointment/Resignation
29/11/17 download Created with Sketch. 207.83KB
RCE Results of Meeting
21/11/17 download Created with Sketch. 277.26KB
RCE 2017 AGM Presentation
21/11/17 download Created with Sketch. 819.39KB
RCE US FDA Grants Qualified Infectious Disease Product Designati
16/11/17PRICE SENSITIVE download Created with Sketch. 279.16KB
RCE Trading Halt Request
14/11/17 download Created with Sketch. 211.05KB
RCE Trading Halt
14/11/17PRICE SENSITIVE download Created with Sketch. 251.91KB
RCE Change in Sydney Office Address
08/11/17 download Created with Sketch. 203.7KB
RCE Cleansing Statement
03/11/17 download Created with Sketch. 78.81KB
RCE Appendix 3B
03/11/17 download Created with Sketch. 568.49KB
RCE Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 211.6KB
RCE Change in substantial holding
25/10/17 download Created with Sketch. 1.64MB
RCE Appendix 3B
25/10/17 download Created with Sketch. 566.36KB
RCE Successful Share Purchase Plan
23/10/17 download Created with Sketch. 244.96KB
RCE Notice of Annual General Meeting/Proxy Form
20/10/17 download Created with Sketch. 608.16KB
RCE Appendix 4G
20/10/17 download Created with Sketch. 255.61KB
RCE Annual Report to shareholders
20/10/17 download Created with Sketch. 4.39MB
RCE Cleansing Statement
03/10/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
03/10/17 download Created with Sketch. 569.1KB
RCE Recce Launches Share Purchase Plan
27/09/17PRICE SENSITIVE download Created with Sketch. 464.2KB
RCE Correction to Appendix 3B
26/09/17 download Created with Sketch. 449.06KB
RCE Cleansing Statement
25/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
25/09/17 download Created with Sketch. 297.11KB
RCE Response to ASX Price Query
18/09/17PRICE SENSITIVE download Created with Sketch. 612.45KB
RCE Investor Presention
15/09/17 download Created with Sketch. 1.64MB
RCE Cleansing Statement
07/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
07/09/17 download Created with Sketch. 335.73KB
RCE Recce Confirms Pre-IND Data Submission to US FDA
07/09/17PRICE SENSITIVE download Created with Sketch. 244.64KB
RCE Appendix 4E and Financial Report
01/09/17PRICE SENSITIVE download Created with Sketch. 1.46MB
RCE Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 212.83KB
RCE Recce Confirms Delivery by Intravenous Drip
31/07/17PRICE SENSITIVE download Created with Sketch. 800.89KB
RCE Cleansing Statement
20/07/17 download Created with Sketch. 78.81KB
RCE Appendix 3B
20/07/17 download Created with Sketch. 335.13KB
RCE Recce achieves milestone with volume production
20/07/17PRICE SENSITIVE download Created with Sketch. 336.66KB
RCE Cleansing Statement
22/06/17 download Created with Sketch. 78.75KB
RCE Appendix 3B
22/06/17 download Created with Sketch. 426.06KB
RCE Recce constructs automated manufacturing facility to support
22/06/17PRICE SENSITIVE download Created with Sketch. 335.97KB
RCE Recce secures up to A$6.05 million investment agreement with
16/06/17PRICE SENSITIVE download Created with Sketch. 326.06KB
RCE Recce moves closer to clinical study application
19/05/17PRICE SENSITIVE download Created with Sketch. 337.1KB
RCE Appendic 4G
16/05/17 download Created with Sketch. 253.55KB
RCE Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 210.77KB
RCE Recce calls for Australian investment in R&D to develop new
19/04/17 download Created with Sketch. 325.49KB
RCE Operational Update
10/04/17PRICE SENSITIVE download Created with Sketch. 1MB
RCE Data from large animal study shows RECCE 327 well tolerated
27/03/17PRICE SENSITIVE download Created with Sketch. 198.96KB
RCE Ceasing to be a substantial holder
15/03/17 download Created with Sketch. 155.48KB
RCE Ceasing to be a substantial holder
15/03/17 download Created with Sketch. 473.01KB
RCE Change of Director's Interest Notice
09/03/17 download Created with Sketch. 247.25KB
RCE Appendix 4D and Interim Financial Statements
28/02/17PRICE SENSITIVE download Created with Sketch. 731.01KB
RCE Microscopy Images of its Synthetic Antibiotic in Action Dest
24/02/17PRICE SENSITIVE download Created with Sketch. 622.67KB
RCE Recce to suspend anti-cancer program
23/02/17PRICE SENSITIVE download Created with Sketch. 185.91KB
RCE Ceasing to be a substantial holder
07/02/17 download Created with Sketch. 709.79KB
RCE Operational Update and Quarterly Cash Flow
30/01/17PRICE SENSITIVE download Created with Sketch. 336.12KB
RCE Director Appointment/Resignation
23/01/17 download Created with Sketch. 182.16KB
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
Last
46.0¢
  Change
0.000 ( 1.08 %)
Open High Low Volume
46.0¢ 47.0¢ 46.0¢ 5566
Last updated 12.56pm 26/07/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.